Danaher Operating Margin 2012-2025 | DHR
Current and historical operating margin for Danaher (DHR) over the last 10 years. The current operating profit margin for Danaher as of September 30, 2025 is 22.92%.
| Danaher Operating Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Operating Income | Operating Margin |
| 2025-09-30 | $24.27B | $4.61B | 19.01% |
| 2025-06-30 | $24.01B | $4.42B | 18.39% |
| 2025-03-31 | $23.82B | $4.83B | 20.26% |
| 2024-12-31 | $23.88B | $4.86B | 20.37% |
| 2024-09-30 | $23.74B | $4.78B | 20.11% |
| 2024-06-30 | $23.57B | $5.00B | 21.22% |
| 2024-03-31 | $23.74B | $5.00B | 21.05% |
| 2023-12-31 | $23.89B | $5.20B | 21.77% |
| 2023-09-30 | $21.03B | $5.01B | 23.82% |
| 2023-06-30 | $23.07B | $5.84B | 25.32% |
| 2023-03-31 | $24.90B | $6.88B | 27.63% |
| 2022-12-31 | $26.64B | $7.54B | 28.29% |
| 2022-09-30 | $26.60B | $7.46B | 28.04% |
| 2022-06-30 | $26.17B | $6.75B | 25.81% |
| 2022-03-31 | $25.63B | $6.55B | 25.56% |
| 2021-12-31 | $24.80B | $6.38B | 25.71% |
| 2021-09-30 | $28.07B | $6.91B | 24.63% |
| 2021-06-30 | $26.72B | $6.69B | 25.04% |
| 2021-03-31 | $24.80B | $5.53B | 22.30% |
| 2020-12-31 | $22.28B | $4.23B | 18.99% |
| 2020-09-30 | $20.39B | $3.59B | 17.61% |
| 2020-06-30 | $18.89B | $3.28B | 17.36% |
| 2020-03-31 | $18.03B | $3.25B | 18.00% |
| 2019-12-31 | $17.91B | $3.27B | 18.25% |
| 2019-09-30 | $15.56B | $2.92B | 18.78% |
| 2019-06-30 | $16.04B | $2.98B | 18.56% |
| 2019-03-31 | $16.57B | $3.03B | 18.30% |
| 2018-12-31 | $17.05B | $3.06B | 17.92% |
| 2018-09-30 | $16.80B | $2.96B | 17.62% |
| 2018-06-30 | $16.48B | $2.89B | 17.53% |
| 2018-03-31 | $16.01B | $2.70B | 16.85% |
| 2017-12-31 | $15.52B | $2.57B | 16.57% |
| 2017-09-30 | $17.83B | $2.77B | 15.51% |
| 2017-06-30 | $17.43B | $2.71B | 15.52% |
| 2017-03-31 | $17.16B | $2.74B | 15.96% |
| 2016-12-31 | $16.88B | $2.74B | 16.20% |
| 2016-09-30 | $13.57B | $2.02B | 14.85% |
| 2016-06-30 | $12.95B | $1.80B | 13.87% |
| 2016-03-31 | $13.66B | $2.02B | 14.78% |
| 2015-12-31 | $14.43B | $2.16B | 14.98% |
| 2015-09-30 | $18.58B | $3.06B | 16.44% |
| 2015-06-30 | $19.78B | $3.44B | 17.40% |
| 2015-03-31 | $19.78B | $3.40B | 17.17% |
| 2014-12-31 | $19.75B | $3.43B | 17.37% |
| 2014-09-30 | $19.60B | $3.43B | 17.51% |
| 2014-06-30 | $19.56B | $3.38B | 17.27% |
| 2014-03-31 | $19.34B | $3.33B | 17.24% |
| 2013-12-31 | $19.12B | $3.28B | 17.13% |
| 2013-09-30 | $18.83B | $3.25B | 17.26% |
| 2013-06-30 | $18.57B | $3.19B | 17.20% |
| 2013-03-31 | $18.39B | $3.16B | 17.19% |
| 2012-12-31 | $18.26B | $3.17B | 17.33% |
| 2012-09-30 | $18.00B | $3.08B | 17.11% |
| 2012-06-30 | $18.03B | $2.97B | 16.46% |
| 2012-03-31 | $17.12B | $2.77B | 16.17% |
| 2011-12-31 | $16.09B | $2.62B | 16.26% |
| 2011-09-30 | $14.61B | $2.40B | 16.40% |
| 2011-06-30 | $13.25B | $2.31B | 17.39% |
| 2011-03-31 | $12.83B | $2.21B | 17.24% |
| 2010-12-31 | $12.55B | $2.05B | 16.33% |
| 2010-09-30 | $11.78B | $1.78B | 15.14% |
| 2010-06-30 | $11.44B | $1.70B | 14.82% |
| 2010-03-31 | $10.90B | $1.52B | 13.97% |
| 2009-12-31 | $10.52B | $1.44B | 13.69% |
| 2009-09-30 | $11.23B | $1.57B | 14.01% |
| 2009-06-30 | $11.69B | $1.63B | 13.95% |
| 2009-03-31 | $12.30B | $1.80B | 14.61% |
| 2008-12-31 | $12.70B | $1.87B | 14.72% |
| 2008-09-30 | $12.66B | $1.91B | 15.08% |
| 2008-06-30 | $12.19B | $1.85B | 15.19% |
| 2008-03-31 | $11.53B | $1.78B | 15.47% |
| 2007-12-31 | $11.03B | $1.74B | 15.79% |
| 2007-09-30 | $10.45B | $1.71B | 16.37% |
| 2007-06-30 | $10.13B | $1.64B | 16.15% |
| 2007-03-31 | $9.84B | $1.57B | 15.98% |
| 2006-12-31 | $9.47B | $1.50B | 15.85% |
| 2006-09-30 | $9.05B | $1.40B | 15.46% |
| 2006-06-30 | $8.61B | $1.33B | 15.48% |
| 2006-03-31 | $8.19B | $1.27B | 15.54% |
| 2005-12-31 | $7.87B | $1.25B | 15.85% |
| 2005-09-30 | $7.70B | $1.23B | 15.96% |
| 2005-06-30 | $7.48B | $1.20B | 16.06% |
| 2005-03-31 | $7.17B | $1.15B | 16.06% |
| 2004-12-31 | $6.89B | $1.11B | 16.04% |
| 2004-09-30 | $6.40B | $1.05B | 16.43% |
| 2004-06-30 | $5.96B | $0.98B | 16.35% |
| 2004-03-31 | $5.64B | $0.90B | 16.03% |
| 2003-12-31 | $5.29B | $0.85B | 15.98% |
| 2003-09-30 | $5.08B | $0.79B | 15.57% |
| 2003-06-30 | $4.92B | $0.76B | 15.48% |
| 2003-03-31 | $4.77B | $0.73B | 15.33% |
| 2002-12-31 | $4.58B | $0.70B | 15.32% |
| 2002-09-30 | $4.22B | $0.55B | 13.10% |
| 2002-06-30 | $3.97B | $0.51B | 12.94% |
| 2002-03-31 | $3.78B | $0.50B | 13.25% |
| 2001-12-31 | $3.78B | $0.50B | 13.27% |
| 2001-09-30 | $3.90B | $0.59B | 15.25% |
| 2001-06-30 | $3.98B | $0.59B | 14.90% |
| 2001-03-31 | $3.92B | $0.57B | 14.64% |
| 2000-12-31 | $3.78B | $0.55B | 14.64% |
| 2000-09-30 | $3.59B | $0.47B | 12.97% |
| 2000-06-30 | $3.39B | $0.44B | 12.92% |
| 2000-03-31 | $3.24B | $0.41B | 12.62% |
| 1999-12-31 | $3.13B | $0.39B | 12.38% |
| 1999-09-30 | $3.08B | $0.22B | 7.07% |
| 1999-06-30 | $3.03B | $0.20B | 6.55% |
| 1999-03-31 | $3.02B | $0.29B | 9.47% |
| 1998-12-31 | $2.91B | $0.37B | 12.61% |
| 1998-09-30 | $2.78B | $0.66B | 23.58% |
| 1998-06-30 | $2.68B | $0.74B | 27.53% |
| 1998-03-31 | $2.56B | $0.72B | 27.97% |
| 1997-12-31 | $2.49B | $0.71B | 28.45% |
| 1997-09-30 | $2.31B | $0.58B | 24.98% |
| 1997-06-30 | $2.16B | $0.46B | 21.13% |
| 1997-03-31 | $1.99B | $0.35B | 17.38% |
| 1996-12-31 | $1.81B | $0.23B | 12.41% |
| 1996-09-30 | $1.75B | $0.32B | 18.50% |
| 1996-06-30 | $1.68B | $0.32B | 18.81% |
| 1996-03-31 | $1.60B | $0.26B | 16.53% |
| 1995-12-31 | $1.52B | $0.22B | 14.12% |
| 1995-09-30 | $1.45B | $0.10B | 6.91% |
| 1995-06-30 | $1.37B | $0.09B | 6.57% |
| 1995-03-31 | $1.34B | $0.12B | 8.84% |
| 1994-12-31 | $1.29B | $0.15B | 11.26% |
| 1994-09-30 | $1.22B | $0.13B | 10.74% |
| 1994-06-30 | $1.18B | $0.12B | 10.04% |
| 1994-03-31 | $1.12B | $0.11B | 9.68% |
| 1993-12-31 | $1.08B | $0.10B | 9.40% |
| 1993-09-30 | $1.05B | $0.09B | 8.67% |
| 1993-06-30 | $1.01B | $0.08B | 8.19% |
| 1993-03-31 | $0.99B | $0.08B | 7.56% |
| 1992-12-31 | $0.96B | $0.07B | 7.01% |
| 1992-09-30 | $0.91B | $0.05B | 5.70% |
| 1992-06-30 | $0.88B | $0.04B | 5.03% |
| 1992-03-31 | $0.84B | $0.04B | 4.52% |
| 1991-12-31 | $0.83B | $0.04B | 4.21% |
| 1991-09-30 | $0.85B | $0.04B | 5.08% |
| 1991-06-30 | $0.87B | $0.06B | 6.57% |
| 1991-03-31 | $0.87B | $0.07B | 7.94% |
| 1990-12-31 | $0.85B | $0.08B | 9.57% |
| 1990-09-30 | $0.79B | $0.09B | 11.73% |
| 1990-06-30 | $0.75B | $0.09B | 12.18% |
| 1990-03-31 | $0.74B | $0.10B | 12.92% |
| 1989-12-31 | $0.76B | $0.10B | 13.34% |
| 1989-09-30 | $0.73B | $0.10B | 14.21% |
| 1989-06-30 | $0.72B | $0.10B | 14.27% |
| 1989-03-31 | $0.72B | $0.11B | 14.58% |
| 1988-12-31 | $0.71B | $0.11B | 14.71% |
| 1988-09-30 | $0.59B | $0.11B | 17.68% |
| 1988-06-30 | $0.62B | $0.10B | 16.43% |
| 1988-03-31 | $0.62B | $0.09B | 14.90% |
| 1987-12-31 | $0.62B | $0.08B | 13.64% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $168.373B | $23.875B |
| Danaher Corporation is a global conglomerate that designs, manufactures and markets diverse lines of professional, industrial, commercial and consumer products. The company's segmental details are provided below: Life Sciences segment offers a broad range of research tools used to analyze a range of critical areas including genes, proteins, metabolites and cells to understand the causes of diseases, identify new therapies, and test new drugs and vaccines. Range of industries served includes biopharmaceutical, food and beverage, medical, aerospace, microelectronics, and general industrial. Diagnostics segment offers analytical instruments, reagents, consumables, software and services that are deployed in reference laboratories, hospitals, physicians' offices and other critical care settings. It helps to diagnose diseases and take suitable treatment decisions. Environmental & Applied Solutions segment offers products and services that help keep food and water supplies safe globally. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HCA Healthcare (HCA) | United States | $107.724B | 17.83 |
| CVS Health (CVS) | United States | $101.935B | 11.72 |
| Elevance Health (ELV) | United States | $82.857B | 12.15 |
| Cencora (COR) | United States | $65.122B | 20.99 |
| Natera (NTRA) | United States | $32.410B | 0.00 |
| DiDi Global (DIDIY) | China | $24.285B | 22.43 |
| Labcorp Holdings (LH) | United States | $20.875B | 15.92 |
| Medpace Holdings (MEDP) | United States | $16.760B | 41.61 |
| BioMerieux (BMXMF) | France | $15.630B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $15.207B | 0.00 |
| Solventum (SOLV) | United States | $14.941B | 14.50 |
| Viatris (VTRS) | United States | $14.697B | 5.48 |
| ICON (ICLR) | Ireland | $14.648B | 14.53 |
| Revvity (RVTY) | United States | $11.840B | 21.80 |
| CochLear (CHEOY) | Australia | $11.530B | 0.00 |
| Charles River Laboratories (CRL) | United States | $10.872B | 20.94 |
| Avantor (AVTR) | United States | $8.461B | 12.93 |
| Caris Life Sciences,�Inc (CAI) | United States | $8.044B | 0.00 |
| HealthEquity (HQY) | United States | $8.044B | 30.08 |
| Sonic Healthcare (SKHHY) | Australia | $7.443B | 0.00 |
| BrightSpring Health Services (BTSG) | United States | $6.769B | 40.35 |
| PACS (PACS) | United States | $6.464B | 39.31 |
| Bausch + Lomb (BLCO) | Canada | $6.096B | 40.02 |
| Sotera Health (SHC) | United States | $5.455B | 26.30 |
| Alignment Healthcare (ALHC) | United States | $4.158B | 0.00 |
| GeneDx Holdings (WGS) | United States | $3.913B | 68.72 |
| Amplifon S.p.A (AMFPF) | Italy | $3.719B | 21.70 |
| Concentras Parent (CON) | United States | $2.551B | 15.92 |
| Progyny (PGNY) | United States | $2.327B | 45.75 |
| Organon (OGN) | United States | $2.093B | 2.21 |
| Surgery Partners (SGRY) | United States | $2.085B | 26.87 |
| Establishment Labs Holdings (ESTA) | United States | $1.986B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.919B | 11.46 |
| Teladoc Health (TDOC) | United States | $1.324B | 0.00 |
| Nutex Health (NUTX) | United States | $1.317B | 10.07 |
| Ardent Health (ARDT) | United States | $1.270B | 4.14 |
| GoodRx Holdings (GDRX) | United States | $0.950B | 15.56 |
| Omada Health (OMDA) | United States | $0.892B | 0.00 |
| CareDx (CDNA) | United States | $0.881B | 14.40 |
| Embecta (EMBC) | United States | $0.756B | 4.30 |
| InnovAge Holding (INNV) | United States | $0.719B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.693B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.606B | 0.00 |
| CryoPort (CYRX) | United States | $0.529B | 0.00 |
| Enhabit (EHAB) | United States | $0.505B | 22.66 |
| Charming Medical (MCTA) | Hong Kong, SAR China | $0.497B | 0.00 |
| Strata Critical Medical (SRTA) | United States | $0.491B | 0.00 |
| SBC Medicals (SBC) | United States | $0.455B | 8.38 |
| Agilon Health (AGL) | United States | $0.411B | 0.00 |
| Oncology Institute (TOI) | United States | $0.411B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.361B | 5.81 |
| QDM (QDMI) | Hong Kong, SAR China | $0.358B | 75.29 |
| Shoulder Innovations (SI) | United States | $0.296B | 0.00 |
| So-Young (SY) | China | $0.266B | 0.00 |
| KindlyMD (NAKA) | United States | $0.188B | 0.00 |
| Beauty Health (SKIN) | United States | $0.186B | 0.00 |
| LifeMD (LFMD) | United States | $0.186B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.142B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.133B | 0.00 |
| DocGo (DCGO) | United States | $0.087B | 0.00 |
| Park Dental Partners (PARK) | United States | $0.059B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.049B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.044B | 0.00 |
| Biodesix (BDSX) | United States | $0.043B | 0.00 |
| Pomdoctor - (POM) | China | $0.032B | 0.00 |
| Synergy CHC (SNYR) | United States | $0.020B | 6.24 |
| Intelligent Bio Solutions (INBS) | United States | $0.017B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.017B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.013B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.012B | 0.00 |
| Lifeward (LFWD) | United States | $0.011B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.009B | 0.00 | |
| SeaStar Medical Holding (ICU) | United States | $0.008B | 0.00 |
| Aclarion (ACON) | United States | $0.003B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.003B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| XWELL (XWEL) | United States | $0.003B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.000B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |